ArticleAmerican journal of medicine open2026
Risk of Heart Failure-related Events in Patients Exposed to Medical Cannabis: A Longitudinal Cohort Study.
Article in American journal of medicine open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of Cannabis use and Survival in patients with heart failure: A claims-based cohort study of commercially insured adults.American heart journal plus : cardiology research and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study examined the association between the authorized prescription of cannabis and heart failure (HF) events. Study design: We conducted a retrospective cohort study of patients who received an authorized prescription of cannabis in Ontario cannabis clinics between 2014-2019 and controls selected from the general population of Ontario. Methods: Ontario's health administrative data and clinical data from the cannabis clinics were used. Inverse probability of treatment weights based on propensity scores were used to minimize confounding between cannabis exposure and the study outcomes. Weighted Cox proportional hazards regressions measured the association between exposure to cannabis and ED/hospitalization for HF (primary outcome), and a secondary outcome that extended the primary outcome by including physician claims for HF. Results: Among 54,006 patients exposed to cannabis and 161,265 controls, 39% were aged ≤ 50 years, and 55% were female. For the primary outcome, incidence rates for ED visits/hospitalization due to HF were 5.87/1000 person-years (95%CI: 5.72-6.03) in the cannabis group and 5.14/1000 person-years (5.05-5.22) in the control group.Patients exposed to cannabis had a higher risk for the primary outcome with a hazard ratio of 1.15 (95%CI: 1.06-1.25). For the secondary outcome, incidence rates were 18.99 (95% CI: 18.55-19.44) in the cannabis group and 16.69 (95% CI: 16.46-16.93) for controls; with a hazard ratio of 1.13 (95% CI: 1.08-1.19). Conclusions: The results suggest a higher risk of heart failure-related events, including emergency department visits, hospitalizations, and outpatient consultations, among patients who were authorized cannabis for medical purposes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.